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Ang-1. A changing balance of these growth factors may contrib-Angiopoietin correlates with glomerular capillary loss in anti-
ute to decreased glomerular vascularity in crescentic GN.glomerular basement membrane glomerulonephritis.
Background. Emerging evidence suggests that endothelial
turnover occurs in several glomerular diseases and correlates
with resolution or progression of glomerular lesions. We hy-
Each adult mammalian kidney receives 10% of thepothesized that the growth factors modulating embryonic kid-
cardiac output, a high blood flow supplying glomerularney endothelial cell survival and capillary morphogenesis may
be implicated in capillary loss that occurs in immune-mediated and peritubular capillaries. Growth factors signaling
glomerulonephritis (GN). through receptor tyrosine kinases (RTK) direct embry-
Methods. GN was induced in C57BL/6 mice by intravenous onic endothelial differentiation [1]. One set of RTK is theadministration of sheep anti-mouse glomerular basement
vascular endothelial growth factor receptors (VEGFR),membrane (GBM) globulin and assessed with markers of vas-
with VEGFR-2 mediating endothelial formation andcularity in glomerular lesions, correlating these with expression
of specific vascular growth factors. VEGFR-1 modulating vessel assembly [1]. These genes
Results. As assessed by periodic acid Schiff staining, 14  are expressed in differentiating metanephric mesen-
4% (mean  SD) glomeruli were affected by sclerosis at 14
chyme and during later nephrogenesis [2–4], and func-days after globulin administration, and 33  5% were affected
tional experiments implicate VEGF-A in glomerularat 21 days. By 21 days, a significant increase of plasma creatinine
and urinary protein occurred. P-selectin expression was in- growth in vivo [5, 6] and in endothelial growth in meta-
creased in glomerular capillaries 14 days after disease induc- nephric organ culture [7].
tion, and capillary loss, as assessed by immunohistochemistry Tie genes constitute another class of endothelial RTKfor platelet-endothelial cell adhesion molecule, vascular endo-
[1]. As endothelia differentiate, the onset of Tie expres-thelial growth factor (VEGF) receptor 2 and the angiopoietin
(Ang) receptor Tie-2, was recorded at 14 and 21 days in glomer- sion postdates VEGFR-2 but precedes maturity; plate-
uli affected by proliferative crescents and/or sclerosis. VEGF-A let-endothelial cell adhesion molecule (PECAM), is ex-
immunostaining, evident in control glomeruli, was qualitatively pressed with Tie-2 during this process [4, 8]. Tie genes
diminished in glomeruli with lesions. Ang-1 immunostaining
are implicated in differentiation of cells that have en-was detected in control glomeruli and was diminished at 14
tered the endothelial lineage and, indirectly, also in re-days after administration of anti-mouse GBM globulin; instead,
Ang-1 was immunolocalized to distal tubules. In contrast, ciprocal signaling from endothelia to maturing pericytes
Ang-2 immunostaining was barely detectable in control glo- and vascular smooth muscle [1]. Tie-1 null-mutants have
meruli but was prominent in disease glomeruli. In GN mice,
impaired vessel integrity and, in Tie-1lcz/Tie-1lczn chime-rare apoptotic glomerular endothelia were detected by electron
ras, mutant cells fail to contribute to renal vasculature,microscopy and in situ end-labeling, but such cells were not
seen in controls. suggesting a nephrogenic role for Tie-1 [9]. Angiopoie-
Conclusions. Loss of glomerular capillaries during the tins (Ang) contain an aminoterminal coiled-coil domain
course of anti-GBM GN in mice was temporally associated mediating the formation of dimers and multimers, withwith decreases in endothelial survival molecules VEGF-A and
carboxyterminal fibrinogen-like domains mediating dif-Ang-1, and with up-regulation of Ang-2, an antagonist of
ferential effects on Tie-2 phosphorylation [10]. Ang-1
binds to and tryosine phosphorylates Tie-2, preventing
Key words: progressive renal disease, glomerular lesions, capillary mor-
endothelial apoptosis and inducing capillary morphogen-phogenesis, vascular endothelial growth factor, Tie-2, sclerosis, cres-
centic glomerulonephritis. esis [11–13], and Ang-1 also reduces capillary plasma
leakage during health and leukocyte transmigration in
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[16], although a single report showed that, at very high [4, 25] for immunohistochemistry (1:500); rabbit anti-
human VEGF-A (A-20; Santa Cruz) for immuno-concentration and prolonged exposure, Ang-2 stimulates
Tie-2 [17]. By destabilizing existing vessels, Ang-2 facili- histochemistry (1:400) and Western blot (1:400); and
rat antimouse VEGFR-2 (Pharmingen) for immuno-tates vascular growth when ambient VEGF is high, but
when VEGF is low, Ang-2 expression causes capillary histochemistry (1:1000). Relevant second antibodies
were purchased from DAKO (Cambridge, Cambridge-loss, for example, in corpus luteum angiogenesis and
regression [16, 18]. Angiopoietins and Tie receptors shire, UK).
genes are expressed in nephrogenesis and Ang-1 en-
Induction of GNhances glomerular vascularization in metanephric organ
culture [2, 4, 19–21]. As assessed by Ang-2 driven LacZ Anti-glomerular basement membrane glomerulone-
phropathy was induced as described [29]. C57BL/6 strainexpression, Ang-2 is expressed in differentiating arterial
smooth muscle and transiently in the mesangial lineage, mice were maintained under pathogen-free conditions at
Monash University (Clayton, Victoria, Australia). Sheepwith hypoxia up-regulating Ang-2 in cultured mouse
mesangial cells [21, 22]. anti-mouse GBM globulin (1.25 mg/10 g body wt) was
administered intravenously to 12-week-old male mice.It has been reported that glomerular endothelial cell
regression, occurring at least partly by apoptosis, is a Mice were studied at 14 and 21 days after the administra-
tion of anti-GBM globulin, at which times the prolifera-feature of certain experimental models of glomerular
disease, including the remnant kidney [23] and immune- tive and sclerotic GN lesions are becoming morphologi-
cally established [29]. Mice that had received no globulinbased glomerulonephritis (GN) [24]. Furthermore, mole-
cular signaling systems controlling nephrogenic endothe- were used as controls. Preliminary analyses revealed no
differences in any measured parameter in control micelial growth are implicated in glomerular and peritubular
capillary remodeling that occurs in animal models, such at 14 versus 21 days, and hence, data sets from these
times were amalgamated. Mice were housed individuallyas acute neprotoxicity induced by folic acid [25], experi-
mental thrombotic microangiopathy [26] and the rem- in cages to collect urine over the final 24 hours of each
experiment, and mice were bled under diethyl ether an-nant kidney [27, 28]. We hypothesized that growth fac-
tors modulating embryonic kidney endothelial cell esthesia (Unilab, Sevenhills, NSW, Australia). Immedi-
ately after death of each mouse, one kidney was removedsurvival and capillary morphogenesis also may be impli-
cated in capillary loss in immune-initiated glomerular for histology while the cortex of the contralateral organ
retained for RNA and protein analyses. For conve-inflammation associated with leukocyte-dependent pro-
liferative and crescentic GN [29]. We demonstrate that nience, in this article animals that did not receive anti-
GBM globulin are referred to as the ‘control’ group,loss of glomerular capillaries in a mouse model of anti-
glomerular basement membrane (GBM) induced GN is whereas those that received the anti-GBM globulin are
the ‘experimental’ group.associated with decreases in endothelial survival mole-
cules VEGF-A and Ang-1, and up-regulation of Ang-2,
Histologyan Ang-1 antagonist. We postulate that a changing bal-
ance of these growth factors may contribute to decreased Kidneys were fixed in Bouin’s fixative, embedded in
paraffin and sectioned at 4m. The following stains wereglomerular vascularity in this type of GN.
performed: hematoxylin and eosin (H&E) for general
histology and periodic acid-Schiff (PAS) for assessment
METHODS
of glomerular sclerosis and detection of proximal tubule
General materials and antibodies brush borders. Glomeruli were examined at their ap-
proximately maximum diameter (that is, equatorial crossUnless otherwise stated, chemicals were obtained
from Sigma-Aldrich Co. (Poole, Dorset, UK). Antibod- sections) and were considered to exhibit crescent forma-
tion when three or more layers of cells were detected inies used were: rabbit antibody to a 20 aa sequence in
the N-terminal of mouse Ang-1 (Alpha Diagnostic In- Bowman’s space. For immunohistochemistry, deparaf-
finized sections were pre-treated with proteinase (100ternational, San Antonio, TX, USA) for immunohis-
tochemistry (1:500) and Western blot (1:1000); rabbit g/mL), proteinase K (100 g/mL) or trypsin (1.0 mg/
mL) for 10 to 25 minutes, depending on the primaryantibody to a 20 aa sequence in the N-terminal of mouse
Ang-2 (Alpha Diagnostic International) for immunohis- antibody. Endogenous peroxidase was quenched with
3% hydrogen peroxide in water for 30 minutes and sec-tochemistry (1:500) and Western blot (1:1000) (note that
Ang-1 and Ang-2 immunizing peptides have no sig- tions were blocked in 10% bovine serum with 0.1%
Tween-20. After incubation sequentially with primarynificant homology); rat anti-mouse PECAM (Phar-
mingen, San Diego, CA, USA) for immunohistochemis- antibodies and biotin-conjugated secondary antibodies,
bound antibodies were detected with a streptavidin-bio-try (1:1000); rat anti-mouse Tie-2 (a gift from Toshio
Suda, Kumamoto University School of Medicine, Japan) tin peroxidase system or Envision kit (Dako, Hamburg,
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Germany). Controls included omission of the primary minutes and separated on 6 to 12% SDS-polyacrylamide
antibodies or pre-incubation of primary antibodies with gel electrophoresis (SDS-PAGE) gel. Proteins were
blocking peptides. Staining of PECAM and in situ end- transferred to nitrocellulose membranes (Amersham
labeling was performed to detect apoptotic endothelia. Pharmacia Biotech) by electroblotting (BioRad). Blots
Sections were pretreated with proteinase K for 15 min- were blocked overnight at 4C with 5% (wt/vol) fat-free
utes and reaction mixture was added and incubated at milk powder, 0.2% bovine serum albumin (BSA) and
37C for two hours. After TUNEL staining using a fluo- 0.3% (vol/vol) Tween-20 in PBS and then incubated with
rescein isothiocyanate detection method (TUNEL kit; appropriate primary antibodies overnight at 4C. After
Boehringer Mannheim, Lewes, East Sussex, UK), sec- washing in blocking solution, blots were incubated for 30
tions were incubated with rat anti-mouse PECAM, and minutes with horseradish peroxidase-conjugated second
then rabbit anti-rat Ig conjugated with Texas Red (1:100;
antibodies in blocking solution. Blots were washed three
Dako) was used as secondary antibody. Sections were
times with blocking solution and once with phosphate-mounted with aqueous mounting medium (Citiflour Ltd,
buffered saline (PBS). Bound antibodies were detec-London, UK) and examined by confocal microscopy.
ted using an enhanced horseradish peroxidase/luminolFor electron microscopy, 100 m thick paraffin sections
chemiluminescence reagent (Amersham Pharmacia Bio-were dewaxed and rehydrated and then fixed in 3%
tech). Proteins were sized with Rainbow markers. Someglutaraldehyde in pH 7.4 0.1 mol/L Na cacodylate and
blots were reprobed after the antibody complex was5 mmol/L NaCl. Ultrathin sections were cut on an RTC
stripped using striping buffer (Chemicon, Harrow, UK).MT6000 ultramicrotome using a Diatome diamond knife
(Agar Scientific Ltd, Stansted, UK). Sections were
Statisticsstained with 25% uranyl acetate in 50% methyl alcohol
and Reynold’s lead citrate, each for 20 minutes and grids Glomeruli containing apoptotic cells were quantified
examined with a JEOL 1200EX electron microscope as follows. Two histological cross-sections of whole kid-
(JEOL, Tokyo, Japan). neys, separated by at least 100 m to avoid counting
the same glomeruli twice, were analyzed from four kid-Northern blotting
ney samples in each group after double-staining with
Total RNA was isolated with Tri-Reagent and 20 g PECAM antisera and TUNEL reagent, as described
was electrophoresed in 1% formaldehyde-denatured
above. For each kidney, glomeruli in both sections wereagarose gel in 1 MOPS buffer, transferred onto Hy-
pooled, and the following was noted: (1) the total numberbond-N membrane (Amersham Pharmacia Biotech, Lit-
of glomeruli, (2) the percentage of these glomeruli whichtle Chalfont, Buckinghamshire, UK) and fixed with UV-
contained one or more TUNEL-positive cells, (3) theStratalinker (Stratagene, La Jolla, CA, USA). Equality
percentage of glomeruli containing cells that wereof loading was confirmed by visualizing 18S rRNA.
TUNEL-positive and also expressed PECAM protein,Ang-1, Ang-2, Tie-2 and VEGF-A mouse cDNA plas-
and (4) the percentage of glomeruli containing one ormids were used for hybridization, as described [20, 22].
more cells that were TUNEL-positive but not immuno-Inserts were isolated with appropriate restriction en-
zymes and random primer labeling was performed with reactive with PECAM antibody. Values were expressed
Prime-a-Gene labeling system (Promega, Southampton, as means SEM. One-way ANOVA and the Bonferroni
UK). Unincorporated labeled-dCTP was removed by Post Hoc test are used to test the statistical differences
using a push-column (Stratagene). Blots were prehybrid- and P  0.05 was considered statistically significant. In-
ized with Quick-Hyb solution (Stratagene) at 65C for tensities of Northern blot and Western blot signals were
30 minutes and hybridized with specific probes at 65C respectively measured relative to 18S rRNA signals or
for two hours. After hybridization the filters were washed G Brilliant blue staining with an image densitometry
twice with 2 standard sodium citrate (SSC) at 65C for analysis program (Phoretix 1D, Newcastle upon Tyne,
30 minutes and once with 0.1 SSC / 0.1% sodium dode- UK), with the mean of the control group was designated
cyl sulfate (SDS) at 65C for 30 minutes. X-ray films
as an arbitrary value of 1. Four samples were used inwere exposed to blots for 24 to 72 hours at 80C.
each data set for Northern blot and three samples for
Western blot. For quantification of histological data, allWestern blotting
glomeruli were examined in one cross-section of eachKidneys were homogenized in RIPA buffer at 4C
kidney (representing 99 to 193 glomeruli per sample),and the supernatants were collected by centrifugation at
and the results (for example, for glomeruli with PAS-13,000 rpm for 30 minutes. Supernatants were used for
positive deposits or apoptosis) expressed as percentages.protein determination (BCA protein assay; Perbio Sci-
Group data were compared by the Turkey test, with Pence UK Ltd, Tattenhall, Cheshire, UK). For Western
blotting, 30 g of protein samples were boiled for five 0.05 considered statistically significant.
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Fig. 1. Glomerular morphology. Sections stained with PAS and hematoxylin. (A) Glomerulus from control kidney. (B) Cellular crescents (arrows)
in two glomeruli on experimental day 14. (C) Sclerotic glomeruli (*) from kidney on experimental day 21. Bars are 80 m.
Fig. 2. P-selectin immunohistochemistry. All sections stained with hematoxylin and reacted with anti-P-selectin antibody. (A) Glomerulus from
control kidney shows faint immunostaining (brown). (B) Prominent immunoreactive P-selectin in a morphologically normal glomerulus from anti-
GBM GN kidney. (C) Crescentic lesion (arrows) in a glomerulus from anti-GBM kidney shows absent immunostaining while P-selectin is expressed
in the intact portion of the tuft. Bars are 80 m.
RESULTS sions, and by experimental day 21 this number had sig-
nificantly (P  0.01) increased to 33.3  5.4% (N  4Induction of anti-GBM GN
kidneys). Such lesions were not observed in kidneys of
Protein excretion (mean  SD) in control mice was control mice.
3.0  1.1 mg/24 h (N  4). Fourteen days after adminis-
tration of anti-GBM globulin, there was a non-significant Detection of glomerular capillaries
increase of proteinuria (4.9  1.9 mg/24 h; N  8). At P-selectin, is a marker of endothelial activation [30]
day 21 after induction of disease, urine protein excretion and was barely detectable using immunohistochemistry
was significantly (P  0.01) increased (10.0  3.8 mg/24 in glomeruli of control kidneys (Fig. 2A). By contrast,
h; N  8). Plasma creatinine concentration in control prominent P-selectin immunostaining was noted 14 days
mice was 25.9  6.3 mol/L (N  4). Fourteen days after administration of anti-GBM globulin in 90% of
after administration of anti-GBM globulin, there was a glomeruli, whether these were histologically normal (Fig.
non-significant increase of plasma creatinine (38.6  7.8 2B), or affected by morphological GN (Fig. 2C). In glo-
mol/L; N  8). At day 21 after induction of disease, meruli with morphological signs of GN at 14 and 21 days
plasma creatinine was significantly (P  0.05) increased after anti-GBM globulin, P-selectin immunostaining was
in the experimental group (43.7  11.9 mol/L; N  8). decreased or absent within the cellular and sclerotic le-
As assessed by histology (Fig. 1), after administration sions (Fig. 2C). Glomerular capillaries were further visu-
of anti-GBM globulin, mice developed a predominantly alized using a battery of endothelial markers: PECAM,
focal and segmental GN. Cellular crescents predomi- VEGFR-2 and Tie-2. In all glomeruli from control ani-
nated at 14 days (Fig. 1B), with sclerotic glomerular mals and also in morphologically normal glomeruli from
lesions more prominent at 21 days (Fig. 1C). For exam- experimental animals, capillaries were distributed evenly
ple, on day 14, there were 14.4  4.3% of glomeruli across glomerular equatorial cross-sections (Fig. 3 A-C).
In contrast, immunostaining for these endothelial mark-(N  4 kidneys) containing PAS-positive segmental le-
Fig. 3. PECAM, VEGFR-2, and Tie-2 immunohistochemistry. Sections stained with hematoxylin. (A, D and G) Reacted with PECAM antibody.
(B, E and H) Reacted with VEGFR-2 antibody. (C, F and I ) Reacted with Tie-2 antibody. (A-C) In control glomeruli, capillaries are immunoreactive
for PECAM, VEGFR-2 and Tie-2. (D-F) In sections from anti-GBM GN kidneys, immunostaining for these endothelial markers is clearly
diminished in cellular lesions (arrows). (G-I) In sections from anti-GBM GN kidneys, endothelial immunostaining is almost absent in sclerotic
glomeruli (*). Bars are 80 m.
Fig. 4. Detection of apoptosis in glomeruli. (A and
B) Immunostained with PECAM antibody and a
Texas red second antibody; additionally, they were
probed with the TUNEL kit, with apoptotic nuclei
appearing green. (A) Glomerulus from control kid-
ney shows no apoptosis in capillaries that express
PECAM. (B) Two apoptotic nuclei are noted in this
glomerulus affected by a segmental lesion in an anti-
GBM GN kidney. One (large arrow) is double-la-
beled and appears yellow and hence is a dying endo-
thelial cell; the other (small arrow) is green and hence
is a non-endothelial apoptotic cell. (C) Electron mi-
croscopic view of a GN glomerulus showing a nucleus
(arrow) in a capillary lumen; it has the condensed
and dense features of an apoptotic body. An erythro-
cyte is indicated (*) in an adjacent capillary. Bars are
40 m in A and B, and 0.5 m in C.
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Table 1. Apoptotic endothelial cells in glomeruli
Gl with TUNEL Gl with TUNEL and PECAM Gl with TUNEL 	ve cells
	ve cells double 	ve cells which were PECAM ve
Group Total Gl %
Control 21213 0.20.1 0.00.0 0.20.1
E14 19814 5.30.5a 1.00.2a 4.90.4a
E21 22412 6.80.3a 1.20.2a 6.10.4a
Group data are given as meanSEM (N  4) in each group. Abbreviations are: Gl, glomeruli; E14, experimental day 14; E21, experimental day 21; TUNEL,
terminal deoxy transferase uridine triphosphate nick end-labeling; PECAM, platelet-endothelial cell adhesion molecule; 	ve, positive; ve, negative.
a P  0.01 in experimental versus control groups
ers was reduced within focal GN lesions, with fewer or staining was noted (Fig. 5B). VEGF-A immunoreactivity
was detected in control glomeruli (Fig. 5C), in a podo-even absence of capillary loops: Figure 3 panels D to
F respectively show PECAM, VEGFR-2 and Tie-2 in cyte-like pattern, as described by Brown et al [31]. At
14 days after administration of anti-GBM globulin, dif-glomeruli with cellular lesions, while Figure 3 panels G
to I depict glomeruli affected by sclerosis where the ferent patterns were noted for all three factors. First,
all glomeruli, whether or not affected by morphologicalsections have been probed with the same group of anti-
bodies. We considered that some capillaries might have evidence of GN, had decreased Ang-1 immunostaining
(Fig. 5D). Prominent Ang-1 immunostaining instead wasbeen ‘lost’ through the process of endothelial apoptosis.
Quantification of cell death revealed that 8.9  0.7% detected in a subset of narrow cortical tubules that were
often located next to glomeruli (Fig. 6). This is consistentglomeruli contained one or more apoptotic nuclei on
experimental day 14, while on experimental day 21, with them being at the top of the ascending limb of loop
of Henle and/or at the start of the distal convoluted11.4  1.1% contained at least one apoptotic cell, with
no significant difference between the counts at 14 and tubule, a conclusion supported by the lack of prominent
brush border, as assessed by PAS staining. Ang-2 immu-21 days. This showed that apoptosis was occurring but
not which cells were undergoing programmed death. Us- noreactivity was evident at 14 days after induction of
GN within the tufts of glomeruli (Fig. 5E). VEGF-Aing PECAM immunostaining and in situ end-labeling in
the same sections, apoptotic glomerular endothelial cells immunoreactive protein appeared less prominent than
in controls in glomeruli affected by cellular crescentswere not observed in kidneys of control mice (Fig. 4A).
In contrast, a subset of apoptotic cells in glomeruli from (Fig. 5F). In glomeruli affected by sclerosis (Fig. 5 G-I),
a broadly similar pattern (that is, decreased Ang-1, in-the experimental groups expressed PECAM (Fig. 4B),
and an electron microscope survey of glomeruli from creased Ang-2 and decreased VEGF-A) was noted. Vas-
cular growth factor proteins also were detected in renalexperimental animals revealed rare apoptotic nuclei
attached to capillaries walls or within their lumens (Fig. arteries (data not shown). Ang-1 was noted in arterial
endothelia in controls, while Ang-2 and VEGF immuno-4C). On further inspection (Table 1), it was noted that
about 1% of all glomeruli in both experimental groups staining was prominent in the muscular layers of renal
arteries from controls; after induction of GN, immuno-contained endothelial cells that were apoptotic; only
rarely did any glomerular cross-section contain more staining for all three factors was maintained, with promi-
nent vascular wall immunoreactivity for all three pro-than one such cell (data not shown). By contrast, control
glomeruli did not contain apoptotic endothelia (Table teins.
1). Glomerular cross-sections containing one or more
Northern and Western blotting for Ang-1, Ang-2non-endothelial apoptotic cells (that is, cells that were
and VEGF-ATUNEL-positive but PECAM-negative) were more com-
Having obtained the immunohistochemical data, de-mon in the experimental groups (5 to 6% of all glomer-
scribed above, we attempted to quantify the expressionuli counted) versus the controls (0.2% of all glomeruli
of these growth factors using Northern and Western blotscounted; Table 1).
of kidney cortex. Transcripts for Ang-1 (4.8 kb), Ang-2
Ang-1, Ang-2 and VEGF immunohistochemistry (2.8 kb) and VEGF-A (3.9 kb) were detected in control
kidneys and organs at 14 and 21 days after induction ofIn control kidneys, Ang-1 immunostaining was noted
in all glomeruli, in a pattern consistent with capillary anti-GBM GN (Fig. 7A). Mean mRNA levels of these
genes, factored for 18S RNA, are shown in Figure 7B.staining (Fig. 5A). Ang-1 protein also was detected in a
capillary-like pattern between cortical tubules that were Levels of transcripts for all three growth factors tended
to increase at experimental day 14 versus untreated con-negative themselves (Fig. 5A). In glomeruli from control
kidneys, absent or minimal glomerular Ang-2 immuno- trols, and this was statistically significant for the angio-
Fig. 5. Ang-1, Ang-2 and VEGF-A immunohistochemistry of glomeruli. All sections were stained with hematoxylin. (A, D and G) Reacted with
antibody to Ang-1. (B, E and H) Reacted with antibody to Ang-2. (C, F and I ) Reacted with VEGF-A antibody. (A-C) In sections from control
kidneys, glomerular capillary loops contain immunoreactive Ang-1 (A) and VEGF-A (C), whereas Ang-2 is barely detectable (B). (D-F) These
are sections from anti-GBM GN kidneys showing cellular lesions (arrows). Ang-1 immunostaining is diminished in glomerular tufts (D), Ang-2
immunostaining is detectable in affected glomeruli (E), and VEGF-A immunostaining appears diminished in affected glomerular tufts (F). (G-I)
In sections from anti-GBM GN kidneys showing sclerotic glomerular lesions (*), immunostaining for Ang-1 (G) and VEGF-A (I) were decreased
versus normals, whereas Ang-2 protein is detectable is some sclerotic glomeruli (H). Bars are 100 m.
poietins. On experimental day 21, Ang-1 and VEGF-A
levels were not significantly different to controls, whereas
Ang-2 mRNA remained elevated. As assessed by West-
ern blot, Ang-1, Ang-2 and VEGF-A signals were de-
tected in all control and experimental kidney samples
(Fig. 8A), and these signals were abolished after prere-
acting primary antibodies with relevant immunizing pep-
tides (data not shown). Ang-1 bands were observed at
50 kD, probably representing the monomer, and at 100
kD, most likely a dimer. The Ang-2 Western blot showed
Fig. 6. Ang-1 immunostaining in distal tubule. The section from a
two-week experimental kidney was probed with Ang-1 antibody and
counterstained with hematoxylin and PAS. Note that there is little
Ang-1 expression in the glomerular lesion, whereas there is prominent
immunostaining in an adjacent thin tubule, which lacks a PAS-positive
brush border. This is likely to be a distal tubule. Bar is 40 m.
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Fig. 7. Northern blotting. (A) Northern blot-
ting for Ang-1, Ang-2, VEGF-A and 18S
mRNA. Note expression of these species in
kidneys from four controls (lanes 1-4) and 14
days (lanes 5-8) and 21 days (lanes 9-12) after
induction of anti-GBM GN. (B) The intensit-
ies of the Ang-1, Ang-2 and VEGF-A signals
were factored for 18S rRNA, and the results
expressed as bar charts (N 4 for each experi-
mental group). The mean intensity of the con-
trol groups was designated as an arbitrary
value of 1. Levels of Ang-1 were significantly
increased at day experimental 14 versus con-
trols, while those for Ang-2 were significantly
increased at experimental day 14 and 21. Ab-
breviations are: C, controls; E14, experimental
day 14; E21, experimental day 21; *P  0.05
versus controls.
major bands at 50 kD and 75 kD, probably representing merular sclerosis, interstitial inflammation and renal im-
pairment develop secondarily to the glomerular inflam-the monomer and a glycosylated form (Alpha Diagnostic
matory response. Local fibrin deposition contributes toInternational data sheet). On the VEGF-A Western blot,
crescent formation, sclerosis and renal impairment [35]a 22 kD was observed, representing a monomer. Using
and plasminogen activators produced by endothelialdensitometry (in the cases of Ang-1 and Ang-2, summing
cells and leukocytes play an important role in regulatingthe signal intensity of the two main bands), a statistically
this process [36].significant increase of Ang-1 protein was found at 14
While many studies have pointed to inflammatory cells(P  0.05) and 21 days (P  0.01) after administration
and glomerular epithelia as being important in the biol-of anti-GBM globulin (Fig. 8B). Mean Ang-2 levels in-
ogy of experimental crescentic GN [37], it is becomingcreased during the course of GN, and this was significant
apparent that the fate of glomeruli in several types ofat day 21 (P  0.05). VEGF-A was significantly (P 
GN may be associated with the turnover of capillaries.0.05) increased versus controls at experimental day 14.
Furthermore, although it is probable that some capillar-
ies are lost by necrosis, especially in the more acute
DISCUSSION models of disease, endothelial apoptosis may be corre-
Anti-glomerular basement membrane induced GN is lated with outcome. Endothelial injury and regeneration
a model of glomerular injury in mice that results from take place respectively during Habu snake venom-
an immune initiated, leukocyte-mediated inflammatory induced GN [38] and anti-Thy 1 antibody-induced GN
response directed against an antigen (sheep globulin) [39] in rats; the latter process is accompanied by upregu-
planted on the glomerular basement membrane. In lated glomerular VEGF expression. Moreover, antago-
C57BL/6 mice, the immune response is predominantly of nism of VEGF activity in the latter model causes a distur-
a Th1 type [32] and requires MHC II dependent antigen bance of capillary remodelling and endothelial apoptosis
presentation [33] and CD4 T cells [29]. This results in a [40]. In other models of glomerular disease, character-
proliferative and crescentic GN, characterized by glo- ized by failure of glomerular morphological recovery,
merular accumulation of macrophages, proliferation of an overall loss of glomerular endothelia takes place. In
five-sixth nephrectomized rats, Kitamura et al reportedintrinsic glomerular cells [34] and fibrin deposition. Glo-
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Fig. 8. Western blotting. (A) Western blots
for Ang-1, Ang-2, VEGF-A. Note expression
of these proteins in three kidney cortex sam-
ples from controls (lanes 1-3) and at 14 days
(lanes 4-6) and 21 days (lanes 7-9) after induc-
tion of anti-GBM GN. (B) Intensities of the
Ang-1, Ang-2 and VEGF-A signals were fac-
tored for G Brilliant blue staining and results
expressed as bar charts (N 3 for each experi-
mental group); for Ang-1 and Ang-2, the two
major protein species were summated. The
mean intensity of the control groups was des-
ignated as an arbitrary value of 1. Levels of
Ang-1 were significantly increased at experi-
mental days 14 and 21 versus controls. Ang-2
levels were significantly increased at experi-
mental day 21. VEGF-A was significantly in-
creased at experimental day 14. Abbreviations
are: C, controls; E14, experimental day 14;
E21, experimental day 21; *P  0.05 and
**P  0.01 versus control.
that diffuse glomerulosclerosis occurred at three-four Western blotting results demonstrate that levels of
Ang-1, Ang-2 and VEGF-A in lysates of kidney cortexmonths, with significant apoptotic deletion of glomerular
endothelia, detected by expression thrombomodulin, an tended to increase by day 14 after administration of anti-
GBM globulin. At experimental day 21, Ang-2 levelsendotheila surface glycoprotein, at three months [23].
Shimuzu et al studied anti-GBM GN in rat after a single remain elevated, whereas VEGF-A was the same as con-
trols. When expression was studied by immunohisto-injection of anti-rat GBM anybody, and found an overall
loss of glomerular endothelia over several weeks, with chemistry, however, a more complex pattern emerged,
with some factors expressed in glomeruli, tubules andan early increase of proliferation followed by apoptotic
deletion of these cells, as assessed by colocalization of arteries. Renal arteries expressed Ang-1, Ang-2 and
VEGF-A, and therefore protein in these structuresTUNEL with thrombomodulin [24]. Masuda et al com-
bined Habu-venom and Thy 1 antibody administration should be taken into account when interpreting Western
blotting using lysates of kidney cortex. Both VEGF-Ato produce a severe lesion with acute destruction of the
glomerular capillary network [41]; despite an up-regula- and Ang-1 protein were detectable in control glomeruli.
The pattern for VEGF-A is compatible with a predomi-tion of glomerular VEGF, endothelial regeneration was
rare and the kidneys proceeded to glomerulosclerosis nantly podocyte localization, as reported by Brown et
al [31], although we cannot exclude lower protein levelsunless rescued by exogenous VEGF administration. Fi-
nally, in a model of glomerular thrombotic microangio- in other intrinsic cells. In addition, Ang-1 immunostain-
ing was evident in control glomeruli. While it is difficultpathy, Kim et al reported that VEGF administration
enhanced glomerular regeneration [26]. to discern exactly which cells contain this protein, we
have previously used RT-PCR on mouse mesangial cellsThe results presented in the current study add a new
perspective to the biology of anti-GBM GN, in terms of demonstrating that they do not express Ang-1 in culture
[22], while other experiments in developing mouse kid-vascular growth factor expression, especially in relation
to the deletion of glomerular endothelia, a process at neys suggested that Ang-1 transcripts are expressed by
podocytes [20]. In this study, we did not detect significantleast partly mediated by apoptosis. The Northern and
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capillary sprouting [45]. Furthermore, with abundantAng-2 expression in control mouse glomeruli; indeed,
VEGF, Ang-2 disrupts vessels, thus facilitating sprout-our previous studies showed that Ang-2 is expressed by
mesangial cells during mouse glomerulogenesis and that ing; conversely, when ambient VEGF is low, Ang-2 is
it is down-regulated in adulthood [21, 22]. While the associated with vessel regression [16, 18]. In glomeruli
exact roles, if any, of either VEGF-A or Ang-1 in the affected by histological lesions, we observed that the
healthy adult glomerulus are unknown, it is possible to distinct pattern of VEGF-A immunostaining evident in
speculate that they both enhance endothelial survival. controls was lost, and was replaced by a low level of
Certainly, both factors have this action on cultured endo- diffuse immunoreactivity. We suggest that this changed
thelia via the PI3K/Akt pathway [42]. Alternatively, glomerular pattern of vascular growth factors (that is,
Ang-1 may act to maintain integrity between glomerular increased Ang-2 with decreased Ang-1 and VEGF) tends
endothelia themselves and between these cells and sup- to be anti-angiogenic, and could enhance endothelial
porting pericytes, as outlined at the beginning of this apoptosis. Indeed, we could not detect apoptotic endo-
article. A low level of Tie-2 tyrosine phosphorylation thelia in control glomeruli, either by electron microscopy
can be detecting in the adult kidney [20], supporting a or in situ end-labeling, but such cells were evident in
possible role for Ang-1. Proof of these hypotheses would experimental glomeruli. Although such apoptotic endo-
require in vivo blockade of both these factors in normal thelial cells were relatively rare (noted in 1% of all
adult mice. glomerular cross-sections in the experimental groups),
After induction of anti-GBM GN, we found marked they could have important biological implications, espe-
changes in these patterns in glomeruli. First, Ang-1 im- cially if the rate of their clearance was rapid. Further-
munolocalization was almost completely lost in glomer- more, there was a loss of glomerular endothelia in this
uli, whether or not they were affected by histological model, with sclerotic lesions containing few, if any, cells
proliferative and/or sclerotic lesions. At first we found reactive with either PECAM, VEGFR-2 or Tie-2 anti-
this extensive pattern surprising; however, as assessed by bodies. This type of change in the balance of several
P-selectin up-regulation, we also found that glomerular vascular growth factors is thought to determine angio-
endothelial ‘activation’ was more extensive than the sub- genesis and vessel regression during physiological states
set of glomeruli affected by gross morphological lesions. such as corpus luteum growth and involution [16, 18], and
Instead of the normal glomerular expression of Ang-1, a in diseases such as impaired cutaneous wound healing in
new pattern became apparent at two weeks after disease diabetic mice [46].
induction, with the factor immunolocalized to cortical However, it is probable that glomerular cell survival is
distal tubules, a site where protein could not be detected affected by a multiplicity of factors, especially in disease
in controls. Isbel et al have observed that tubular macro- states. Based on studies in other systems, pro-apoptotic
phage colony stimulating factor is up-regulated in an stimuli include other secreted factors (such as angio-
accelerated model of anti-GBM GN, possibly by cytokines statin, endostatin, transforming growth factor 
1, tumor
released by inflamed glomeruli [43], and we speculate necrosis factor) and physical factors such as intracellular
that a similar mechanism may apply to Ang-1 induction. acidosis and ischemia/reperfusion, while anti-apoptotic
Interestingly, Long et al found that distal convoluted stimuli include fibroblast and hepatocyte growth factors
tubules expressed Ang-1 protein after folic acid-induced
and extracellular matrix components [47]; some of these
nephropathy in mice [25], and our preliminary data show
also may be operative in anti-GBM GN. In future, the
that a mouse distal tubule line can express Ang-1 (ab-
significance of each factor will need to be explored bystract; Long et al, J Am Soc Nephrol 12:656A, 2001). In
functional experiments. It will be of special interest to seeaddition, in our current model, Ang-2 became detectable
whether Ang-1 administration can prevent glomerularin glomeruli affected by histological proliferative and/or
endothelial loss in anti-GBM GN, since the factor en-sclerotic lesions. Previous work has shown that mesangial
hances the appearance of mouse metanephric glomerularcells express Ang-2 during glomerulogenesis in vivo and
capillary loops in vitro [4] and augments revasculariza-that cultured mesangial cells from normal adult mice up-
tion of rabbit ischemic hindlimbs [48], while transgenicregulate Ang-2 transcripts and protein expression upon
overexpression in mice also increases tissue vasculariza-exposure to hypoxia [21, 22]; other evidience suggests
tion [49].that Ang-2 expression by endothelia can be modulated
by inflammation [44]. Some of these factors may be oper-
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